Tag Archive for: Lausanne

Alzheimer_semaglutide_483897781_059ZuRgXrKJ8ubHxTiCeiYY6BOdGSl4Zadobe.stock.com - ipopba
Alzheimer

J&J stops enrollment in an AC Immune-partnered Alzheimer trial, but the reason is not yet clear

A pause in the collaborative Alzheimer trial of Johnson & Johnson and partner AC Immune from Switzerland raises some questions. Whether the pause has something to do with overall recruting difficulties or with the application of the drug under investigation is not yet clear.

Read more
Approved antibody drug conjugate against different B-cell cancers ©ADC therapeutics SA

Swedish SOBI awarded rights to market Zynlonta from ADC therapeutics

In a deal worth around USD435m Swiss ADC therapeutics grants Swedish Orphan Biovitrum (SOBI) the rights to market freshly approved Zynlonta outside the US.

Read more